Actionable news
All posts from Actionable news
Actionable news in LXRX: Lexicon Pharmaceuticals, Inc.,

Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q3 2015 Results - Earnings Call Transcript


Good morning. My name is Lori, and I will be your conference operator today. At this time, I would like to welcome everyone to your Lexicon Pharmaceuticals’ third-quarter financial results conference call. [Operator Instructions]

Thank you. I will now turn the call over to Chas Schultz to begin.

Chas Schultz - Director of Financial Analysis

Thank you, Lori. Good morning and welcome to the Lexicon Pharmaceuticals’ third-quarter 2015 conference call. I’m Chas Schultz and with me today are Lonnel Coats, Lexicon’s President and Chief Executive Officer; Dr. Pablo Lapuerta, Lexicon’s Executive Vice President and Chief Medical Officer; Jeff Wade, Lexicon’s Executive Vice President of Corporate and Administrative Affairs and Chief Financial Officer; and John Northcott, Lexicon’s Chief Commercial Officer.

We expect that you have seen a copy of our Sanofi collaboration and our Q3, 2015 earnings press releases that were distributed this morning. During this call we will review the information provided in those releases, provide an update on our clinical programs and then use the remainder of our time to answer your questions.

If you would like to view the slides for today’s call please access the Lexicon’s website at